GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Net Margin %

Kangstem Biotech Co (XKRX:217730) Net Margin % : -514.53% (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kangstem Biotech Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Kangstem Biotech Co's Net Income for the three months ended in Sep. 2024 was ₩-4,030 Mil. Kangstem Biotech Co's Revenue for the three months ended in Sep. 2024 was ₩783 Mil. Therefore, Kangstem Biotech Co's net margin for the quarter that ended in Sep. 2024 was -514.53%.

The historical rank and industry rank for Kangstem Biotech Co's Net Margin % or its related term are showing as below:

XKRX:217730' s Net Margin % Range Over the Past 10 Years
Min: -1783.74   Med: -187.46   Max: -57.48
Current: -57.48


XKRX:217730's Net Margin % is ranked better than
60.22% of 1013 companies
in the Biotechnology industry
Industry Median: -140.3 vs XKRX:217730: -57.48

Kangstem Biotech Co Net Margin % Historical Data

The historical data trend for Kangstem Biotech Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangstem Biotech Co Net Margin % Chart

Kangstem Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -410.26 -202.14 -172.10 -124.14 -172.77

Kangstem Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -428.73 -59.17 -136.05 206.83 -514.53

Competitive Comparison of Kangstem Biotech Co's Net Margin %

For the Biotechnology subindustry, Kangstem Biotech Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kangstem Biotech Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kangstem Biotech Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Kangstem Biotech Co's Net Margin % falls into.



Kangstem Biotech Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Kangstem Biotech Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-21949.168/12704.101
=-172.77 %

Kangstem Biotech Co's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-4030.464/783.326
=-514.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kangstem Biotech Co  (XKRX:217730) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Kangstem Biotech Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Kangstem Biotech Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangstem Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
512 Teheran-ro, Gangnam-gu, 17th Floor, Sinan Building, Seoul, KOR
Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.

Kangstem Biotech Co Headlines

No Headlines